Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The EMBO Journal|June 18, 2002
Crystal structure of vesicular stomatitis virus matrix proteinMartin Gaudier, Yves Gaudin, Marcel Knossow
Science (New York, N.Y.)|September 1, 2007
Structural basis of DNA replication origin recognition by an ORC proteinMartin Gaudier, Barbara S Schuwirth, Sarah L Westcott, et al.
Nature|November 13, 2004
Crystal structure of RecBCD enzyme reveals a machine for processing DNA breaksMartin R Singleton, Mark S Dillingham, Martin Gaudier, et al.
Journal of Molecular Biology|September 19, 2006
Biochemical analysis of a DNA replication origin in the archaeon Aeropyrum pernixIan Grainge, Martin Gaudier, Barbara S Schuwirth, et al.
Diabetes, Obesity & Metabolism|June 21, 2018
Ultra-rapid BioChaperone Lispro improves postprandial blood glucose excursions vs insulin lispro in a 14-day crossover treatment study in people with type 1 diabetesGrit Andersen, Grégory Meiffren, Daniela Lamers, et al.
Diabetes, Obesity & Metabolism|August 7, 2024
ADO09, a co-formulation of pramlintide and insulin A21G, lowers body weight versus insulin lispro in type 1 diabetesGrit Andersen, Rosy Eloy, Tim Heise, et al.
Diabetes, Obesity & Metabolism|January 12, 2023
A co-formulation of pramlintide and insulin A21G (ADO09) improves postprandial glucose and short-term control of mean glucose, time in range, and body weight versus insulin aspart in adults with type 1 diabetesGrit Andersen, Rosy Eloy, Susanne Famulla, et al.
Diabetes, Obesity & Metabolism|March 5, 2019
Better glycaemic control with BioChaperone glargine lispro co-formulation than with insulin lispro Mix25 or separate glargine and lispro administrations after a test meal in people with type 2 diabetesGrégory Meiffren, Theresa Herbrand, Ernestos Anastassiadis, et al.
Cell|May 28, 2004
The beta-thymosin/WH2 domain; structural basis for the switch from inhibition to promotion of actin assemblyMaud Hertzog, Carine van Heijenoort, Dominique Didry, et al.
Diabetes, Obesity & Metabolism|December 18, 2020
ADO09, a co-formulation of the amylin analogue pramlintide and the insulin analogue A21G, lowers postprandial blood glucose versus insulin lispro in type 1 diabetesGrit Andersen, Grégory Meiffren, Susanne Famulla, et al.
Pageof 2